L U Wölfer, S Goerdt, K Schröder, C C Zouboulis, C E Orfanos
In recent years, interferon-alpha has become widely used for systemic therapy of tumours and infectious diseases. Well-known cutaneous side effects include dry skin, pruritus and hair loss. Since 1986, 17 patients with renal cell carcinoma, malignant melanoma, hepatitis B and C, carcinoid syndrome and hairy cell leukemia have been reported in whom psoriasis with or without psoratic B joint involvement was induced or exacerbated by systemic interferon-alpha therapy. In these patients, the drug was discontinued because of the severity of the psoriatic symptoms induced...
February 1996: Der Hautarzt; Zeitschrift Für Dermatologie, Venerologie, und Verwandte Gebiete